Arcturus Therapeutics Holdings (ARCT) Research & Development (2018 - 2026)
Arcturus Therapeutics Holdings' Research & Development came in at $17.52 million for Q2 2026, down 40.8% from $29.58 million a year earlier and down 18.6% from the prior quarter.
Powered by 
Analysis
Arcturus Therapeutics Holdings (ARCT) Research & Development (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcturus Therapeutics Holdings reported Research & Development of $86.78 million, down 41.1% year-over-year; for FY2025, it came in at $112.21 million, down 42.5% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
- Going back by year, Research & Development was $195.16 million in FY2024 (+1.6%), $192.13 million in FY2023 (+30.0%), $147.75 million in FY2022 (-15.0%) and $173.76 million in FY2021 (+200.4%).
- The Q2 2026 figure represents the lowest quarterly Research & Development since Q2 2020.
- Year-over-year, Research & Development has declined for six consecutive quarters, with an average decline of 31.5% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2021 (growth of 156.5%), and the weakest in Q2 2025 (a decline of 49.6%).
- Business Quant data shows ARCT's Research & Development at $21.53 million (Q1 2026), $24.48 million (Q4 2025) and $23.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Arcturus Therapeutics Holdings | 411.00 Mn | -403.13 Mn | - | 17.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.52 Mn |
| Mar 31, 2026 | 21.53 Mn |
| Dec 31, 2025 | 24.48 Mn |
| Sep 30, 2025 | 23.27 Mn |
| Jun 30, 2025 | 29.58 Mn |
| Mar 31, 2025 | 34.89 Mn |
| Dec 31, 2024 | 43.78 Mn |
| Sep 30, 2024 | 39.13 Mn |
| Jun 30, 2024 | 58.67 Mn |
| Mar 31, 2024 | 53.57 Mn |
| Dec 31, 2023 | 36.62 Mn |
| Sep 30, 2023 | 51.08 Mn |
| Jun 30, 2023 | 52.67 Mn |
| Mar 31, 2023 | 51.77 Mn |
| Dec 31, 2022 | 26.98 Mn |
| Sep 30, 2022 | 37.69 Mn |
| Jun 30, 2022 | 38.19 Mn |
| Mar 31, 2022 | 44.89 Mn |
| Dec 31, 2021 | 32.63 Mn |
| Sep 30, 2021 | 45.40 Mn |
API Access
Arcturus Therapeutics Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();